2025. Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models. The Review of Diabetic Studies . (Sep. 2025), 1–21. DOI:https://doi.org/10.1900/q356v768.